Skip to main content
JAGX
NASDAQ Life Sciences

Jaguar Health 合资公司启动可可提取物用于GLP-1后体重减轻的前临床研究

feedReported by Acceswire
Sentiment info
Positive
Importance info
7
Price
$0.503
Mkt Cap
$1.879M
52W Low
$0.462
52W High
$15.48
Market data snapshot near publication time

summarizeSummary

Magdalena Biosciences 是Jaguar Health (JAGX)和Filament Health (FLHLF)的合资公司，已经启动了一项前临床研究，评估整叶可可提取物对食欲抑制的作用，特别针对GLP-1后体重减轻管理。对于Jaguar Health来说，这代表着在推进新型药物候选进入其开发管道方面迈出了具体的一步。这一消息也影响了Filament Health，后者最近宣布将于3月10日被Red Light Holland Corp.收购，这使得这一资产成为收购方的资产开发。虽然目前处于前临床阶段，但这一启动表明在潜在的大型市场中取得了进展，交易者将监测有关该研究结果和任何临床试验进展的未来更新。

在该公告发布时，JAGX的交易价格为$0.50，交易所为NASDAQ，所属行业为Life Sciences，市值约为$187.9万。 52周交易区间为$0.46至$15.48。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：Acceswire。

show_chartPrice Chart

Share this article

Copied!

feed JAGX - Latest Insights

JAGX
Apr 27, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Jaguar Health Announces 1-for-35 Reverse Stock Split to Meet Nasdaq Listing Requirements
Sentiment: Negative
View Wiseek Article
JAGX
Apr 27, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
8
1-for-35 Reverse Stock Split Set for Jaguar Health as Nasdaq Grants Delisting Extension
Sentiment: Neutral
View Wiseek Article
JAGX
Apr 21, 2026, 8:22 AM EDT
Filing Type: PRE 14A
Importance Score:
10
Jaguar Health Seeks Shareholder Approval for Highly Dilutive $42.4M Financing to Address Capital Needs
Sentiment: Negative
View Wiseek Article
JAGX
Apr 21, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Stockholders Approve Massive Share Increase, Two Reverse Splits, and $10.8M Debt Conversion
Sentiment: Negative
View Wiseek Article
JAGX
Apr 13, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
7
Jaguar Health to Leverage AI, Pursue FDA Breakthrough Status for Crofelemer in Rare Disease
Sentiment: Positive
View Wiseek Article
JAGX
Apr 09, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Jaguar Health Believes It Has Regained Nasdaq Stockholders' Equity Compliance, Averting Delisting Threat
Sentiment: Positive
View Wiseek Article
JAGX
Apr 08, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
7
Jaguar Health Completes Pivotal Trial for Canine Diarrhea Drug Crofelemer, Eyes Full FDA Approval
Sentiment: Positive
View Wiseek Article
JAGX
Apr 07, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Jaguar Health Reports Deepening Losses and Nasdaq Delisting Threat Amidst 2025 Financials
Sentiment: Negative
View Wiseek Article
JAGX
Apr 07, 2026, 6:10 AM EDT
Filing Type: 10-K
Importance Score:
9
Jaguar Health Faces Imminent Nasdaq Delisting, Warns of Going Concern Amidst Massive Potential Dilution
Sentiment: Negative
View Wiseek Article
JAGX
Mar 24, 2026, 5:06 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Jaguar Health Seeks Shareholder Approval for Massive Dilution, Two Extreme Reverse Stock Splits
Sentiment: Negative
View Wiseek Article